N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-alpha-D-galactosaminyl-(1<->1')-L-serine(2-) residue

Term ID

CHEBI:156397

Synonyms

a 3-O-{N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-alpha-D-galactosaminyl}-L-serine residue
alpha-NeuNAc-(2->3)-beta-D-Gal-(1->3)-[alpha-NeuNAc-(2->6)]-alpha-D-GalNAc-(1<->1')-L-Ser(2-) residue
N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-alpha-D-galactosaminyl-(1<->1')-L-Ser(2-) residue

Definition

References

PMID:8631773

Ontology

ChEBI ( EBI )

Relationships

is a type of: L-serine derivative

L-serine derivative Show first 5 Terms

Phenotype

Phenotype resulting from N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-alpha-D-galactosaminyl-(1<->1')-L-serine(2-) residue

Phenotype where environments contain N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-alpha-D-galactosaminyl-(1<->1')-L-serine(2-) residue

Phenotype modified by environments containing N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminosyl-(2->6)]-N-acetyl-alpha-D-galactosaminyl-(1<->1')-L-serine(2-) residue

Human Disease Model